Pravastatin to Prevent Preeclampsia
A phase 3 trial registered on ClinicalTrials.gov. The registry status is terminated. It enrolled 102 participants.
Also called NCT03944512
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose prevention
- Phase
- Phase 3
- Enrolled
- 102 participants
- Sponsor
- Registry
-
NCT03944512
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States
- Registry status
- Terminated
Technical summary
Registry record NCT03944512. Randomized; double masking; primary purpose prevention. Start 2019-07-17 (actual); primary completion 2021-06-06 (actual). Results posted on 2025-12-23.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Pravastatin to Prevent Preeclampsia
- Acronym
- Pravastatin
- Condition
- Preeclampsia
- Condition
- Obstetric Labor Complications
- Condition
- Hypertension in Pregnancy
- Intervention (Drug)
- Pravastatin
- Intervention (Other)
- Placebo
- Lead sponsor
- The George Washington University Biostatistics Center
- Collaborator
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
- Collaborator
- National Heart, Lung, and Blood Institute (NHLBI)
Record details
- Record id
cardio:ct-nct03944512- Content hash
28226bf3fb0805416be739ef2497a26ae483580451acb355eeda43ba159f0cec